Your browser doesn't support javascript.
loading
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O(6) -methylguanine DNA methyltransferase expression.
Brandwein, Joseph M; Kassis, Jeannine; Leber, Brian; Hogge, Donna; Howson-Jan, Kang; Minden, Mark D; Galarneau, André; Pouliot, Jean-François.
Affiliation
  • Brandwein JM; Princess Margaret Hospital, Toronto, ON, Canada.
Br J Haematol ; 167(5): 664-70, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25160658
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / DNA Modification Methylases / Leukemia, Myeloid, Acute / Gene Expression Regulation, Enzymologic / Gene Expression Regulation, Leukemic / Antineoplastic Agents, Alkylating / Tumor Suppressor Proteins / Dacarbazine / DNA Repair Enzymes Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Animals / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2014 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / DNA Modification Methylases / Leukemia, Myeloid, Acute / Gene Expression Regulation, Enzymologic / Gene Expression Regulation, Leukemic / Antineoplastic Agents, Alkylating / Tumor Suppressor Proteins / Dacarbazine / DNA Repair Enzymes Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Animals / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2014 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido